Clinical Trials on DSM-IV Schizophrenia
Total 6806 results
-
National Institute of Mental Health and Neuro Sciences...Recruiting
-
University of PittsburghNational Institute of Mental Health (NIMH)Recruiting
-
Central Institute of Mental Health, MannheimRecruiting
-
Hôpital le VinatierRecruiting
-
Central Institute of Mental Health, MannheimRecruiting
-
Centre for Addiction and Mental HealthRecruiting
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceNot yet recruiting
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SActive, not recruiting
-
Karuna TherapeuticsTerminated
-
Organon and CoMeiji Seika Pharma Co., Ltd.Completed
-
SyneuRx International (Taiwan) CorpTerminatedSchizophreniaUnited States, Taiwan
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)Active, not recruiting
-
VA Office of Research and DevelopmentUniversity of California, San Francisco; VA Greater Los Angeles Healthcare...Terminated
-
Zhejiang Jingxin Pharmaceutical Co., Ltd.Shanghai Mental Health CenterCompleted
-
Grupo PulsoHospital de Sant Pau; Nurogames GmbH; Fundació Tic Salut i SocialCompleted
-
Imperial College LondonKing's College London; University College, London; University of Oxford; University... and other collaboratorsCompletedSchizophreniaUnited Kingdom
-
Sumitomo Pharma Co., Ltd.TerminatedSchizophreniaJapan, Taiwan, China, Philippines
-
Hebei Province Veterans HospitalCompleted
-
Centre for Addiction and Mental HealthNational Alliance for Research on Schizophrenia and Depression; Canadian Institutes...Active, not recruiting
-
Boehringer IngelheimCompletedSchizophreniaUnited States, United Kingdom, Australia, Canada, France, New Zealand
-
Hikma Pharmaceuticals LLCWinterlight LabsCompletedSchizophreniaAlgeria, Egypt, Jordan, Saudi Arabia
-
National Taipei University of Nursing and Health...Completed
-
Indiana UniversityCompletedSchizophreniaUnited States
-
Cerevel Therapeutics, LLCCompletedSchizophreniaBelgium, United States
-
Vanda PharmaceuticalsCompletedSchizophreniaUnited States
-
University Hospital, ToulouseCompleted
-
Merck Sharp & Dohme LLCCompleted
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); Janssen Scientific Affairs, LLCCompletedSchizophreniaUnited States
-
Alkermes, Inc.CompletedSchizophreniaUnited States
-
Centre for Addiction and Mental HealthCompletedSchizophreniaCanada
-
Intra-Cellular Therapies, Inc.CompletedSchizophreniaUnited States
-
Central South UniversityShanghai Mental Health CenterActive, not recruiting
-
Hôpital le VinatierCompleted
-
Cerevance Alpha, Inc.Completed
-
University of Maryland, BaltimoreNational Institute of Mental Health (NIMH)Completed
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)Active, not recruiting
-
SunovionCompleted
-
Parc de Salut MarCompleted
-
Sumitomo Pharma Co., Ltd.Completed
-
Sumitomo Pharma Co., Ltd.CompletedSchizophreniaJapan, Korea, Republic of, Malaysia, Taiwan
-
Sumitomo Pharma Co., Ltd.CompletedSchizophreniaChina, Japan, Korea, Republic of, Malaysia, Philippines, Russian Federation, Taiwan, Ukraine
-
AbbVieTerminatedSchizophreniaUnited States, Serbia, Korea, Republic of, Malaysia, Poland, Bulgaria, Ukraine, Puerto Rico, Romania, Taiwan, Thailand
-
Merck Sharp & Dohme LLCCompleted
-
Organon and CoCompleted
-
Organon and CoCompleted
-
Organon and CoCompleted
-
Hôpital le VinatierCompleted
-
University of Maryland, BaltimoreStanley Medical Research InstituteCompleted
-
University of Maryland, BaltimoreNational Institute of Mental Health (NIMH); Mitsubishi Tanabe Pharma CorporationCompleted